RA PHARMA Trademark

Trademark Overview

On Wednesday, January 6, 2016, a trademark application was filed for RA PHARMA with the United States Patent and Trademark Office. The USPTO has given the RA PHARMA trademark a serial number of 86867374. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 5, 2024. This trademark is owned by Ra Pharmaceuticals, Inc.. The RA PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; for the treatment of fibrotic and inflammatory disorders; for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; as anti-viral, anti-bacterial, or anti-fungal agents; none of the foregoing for prevention or treatment of rheumatoid arthritis
ra pharma

General Information

Serial Number86867374
Word MarkRA PHARMA
Filing DateWednesday, January 6, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 5, 2024
Registration Number5297161
Registration DateTuesday, September 26, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 14, 2016

Trademark Statements

Description of MarkThe mark consists of the word "PHARMA" to the right of the word "RA" which is on the solid outline of a circle, where the solid outline fades from dark near the word "RA" to lighter farthest away from the word "RA".
Goods and ServicesPharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; for the treatment of fibrotic and inflammatory disorders; for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; as anti-viral, anti-bacterial, or anti-fungal agents; none of the foregoing for prevention or treatment of rheumatoid arthritis
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 5, 2024
Primary Code005
First Use Anywhere DateTuesday, January 17, 2017
First Use In Commerce DateTuesday, March 14, 2017

Trademark Owner History

Party NameRa Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameRa Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameRa Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Friday, January 15, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, January 9, 2016NEW APPLICATION ENTERED
Thursday, January 14, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 21, 2016ASSIGNED TO EXAMINER
Wednesday, April 27, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, May 25, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 22, 2016ASSIGNED TO LIE
Tuesday, April 26, 2016DATA MODIFICATION COMPLETED
Wednesday, April 27, 2016EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 27, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 27, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, April 27, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 9, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, January 23, 2017SOU EXTENSION 1 GRANTED
Tuesday, June 14, 2016PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 27, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 24, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 24, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 23, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 23, 2017SOU TEAS EXTENSION RECEIVED
Monday, January 23, 2017SOU EXTENSION 1 FILED
Thursday, August 3, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 25, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 26, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, September 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 10, 2017TEAS STATEMENT OF USE RECEIVED
Monday, July 10, 2017USE AMENDMENT FILED
Thursday, August 3, 2017STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 24, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 25, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, July 7, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 7, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, July 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 25, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 25, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 25, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 26, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 5, 2024CANCELLED SEC. 8 (6-YR)
Thursday, July 7, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

pharma system anti treatment disorders prevention ophthalmology gastroenterological transplantation organ hematology